-
Plant Cell Lysis Buffer: From Extraction to IP
2026-09-26
Discover how Plant Cell Lysis Buffer for WB and IP supports non-denaturing plant protein extraction and downstream analysis. A practical assay-design perspective connects careful sample preparation with mechanistic protein research—without assuming that findings from cancer cells transfer directly to plants.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-09-26
A study in rat dental follicle cells found that puerarin increased osteogenic readouts alongside activity in the nitric oxide–sGC–cGMP–PKG signaling axis. Reversal of several effects by NOS inhibition supports pathway involvement, while leaving dose-response, isoform-specific, and in-vivo questions open.
-
CFDA SE Cell Tracer Kit: Practical Guide
2026-09-25
The CFDA SE Cell Tracer Kit provides covalent fluorescent labeling for tracking cell populations through cell proliferation studies and lineage tracing. Use it when persistent labeling is needed; it is not suited to reversible labels or real-time monitoring of physiological changes.
-
CNQX: AMPA/Kainate Antagonism in Neural Circuits
2026-09-25
CNQX, also known as 6-cyano-7-nitroquinoxaline-2,3-dione, is a competitive AMPA and kainate receptor antagonist used to investigate excitatory synaptic signaling. In a rat cNTS–PVN cardiovascular study, CNQX did not reproduce the attenuation observed with an NMDA receptor antagonist, illustrating how receptor-selective tools can distinguish circuit mechanisms.
-
PD 0332991: A Genomic Gate for CDK4/6 Studies
2026-09-24
PD 0332991 (Palbociclib HCl) is a selective CDK4/6 inhibitor, but its effects depend on an intact downstream Rb pathway. This article connects mesothelioma genomics to practical assay design, showing how RB1 status can shape—not predetermine—a research response.
-
Simvastatin (Zocor): Applied Research Workflows
2026-09-24
Use Simvastatin to connect HMG-CoA reductase inhibition with measurable lipid-metabolism and hepatic cancer-cell phenotypes. This guide covers stock preparation, dose selection, orthogonal readouts, and practical controls—while separating established statin biology from methods borrowed from neuronal stress research.
-
A23187, Free Acid: From Calcium Flux to Translation
2026-09-23
A mechanistic and translational guide to using A23187, free acid as a calcium ionophore for separating intracellular calcium signaling, mitochondrial apoptosis, ROS generation, and genuine cell killing from nonspecific viability loss.
-
Linoleic Acid Workflows for Oxidative Stress
2026-09-23
Linoleic Acid provides a defined C18:2(9Z,12Z) stimulus for oxidative stress, erythrocyte injury, membrane, migration, and deficiency studies. This guide connects practical dosing and handling decisions with the AMPK–MNK–P-eIF4E biology reported in fasting and ketogenic-diet research.
-
BKT140 (BL-8040) CXCR4 Antagonist
2026-09-22
BKT140, also called BL-8040 and TF 14016, is an orally bioavailable CXCR4 antagonist for oncology research. It supports studies of CXCR4-mediated chemotaxis inhibition, tumor-cell survival, apoptosis induction, and hematopoietic stem cell mobilization.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-09-21
A 2025 GeroScience study developed a drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibitors at substantially lower concentrations than a wild-type yeast background. The system identified activity from Torin1, omipalisib, AZD8055, and aminophylline while finding no evidence of TOR inhibition for several tested compounds, including Canagliflozin.
-
Gingerenone A Re-sensitizes RCC to Sunitinib
2026-09-21
The reference study identifies gingerenone A as a metabolic intervention that targets LDHA-driven glycolysis and restores sunitinib responsiveness in renal cell carcinoma models. Its combination of computational target discovery, metabolic rescue experiments, drug-combination analysis, and in vivo validation supports a mechanistic link between glycolytic suppression, HIF-1α signaling, and resistance reversal.
-
Linoleic Acid (C18:2) Protocol and QC Guide
2026-09-20
Linoleic Acid (SKU C3108) provides a defined C18:2(9Z,12Z) fatty acid input for oxidative stress, membrane, erythrocyte, migration, and nutritional deficiency workflows. It is water-insoluble, requires an ethanol- or DMSO-based preparation, and should be used freshly rather than from long-stored solutions.
-
AKT Inhibitors: Mechanisms, Resistance, and Combinations
2026-09-19
Kostaras and colleagues systematically compared ATP-competitive and allosteric AKT inhibitors using biochemical, cellular, structural, and phosphoproteomic approaches. Their findings show that inhibitor class, AKT isoform, mutation status, and non-catalytic signaling can strongly shape drug response, providing a framework for rational combination studies.
-
Pazopanib Hydrochloride: Smarter In Vitro Assays
2026-09-19
Build more informative oncology experiments with Pazopanib Hydrochloride by separating growth arrest from true cell killing. This workflow combines target-aware dosing, time-resolved viability measurements, and practical troubleshooting for renal cell carcinoma, soft tissue sarcoma, and angiogenesis models.
-
Alternariol and Liver Fibrosis: Study Insights
2026-09-18
The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can drive LX-2 hepatic stellate cells toward a contractile, myofibroblast-like phenotype, whereas tenuazonic acid produced no significant response in the reported model. By combining lncRNA-mRNA omics with pathway analysis, the work connects Alternaria-toxin exposure with NF-κB activation, ferroptosis, and AMPK/AKT/mTOR-related autophagy, while also examining CotA laccase as a possible AOH detoxification strategy.